Pharmacological treatment of knee osteoarthritis: Special considerations of the new German guideline | Zendy

Jürgen Steinmeyer | Zendy; Fritjof Bock | Zendy; J. Stöve | Zendy; Jörg Jerosch | Zendy; Johannes Flechtenmacher | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pharmacological treatment of knee osteoarthritis: Special considerations of the new German guideline

Author(s) -

Jürgen Steinmeyer,

Fritjof Bock,

J. Stöve,

Jörg Jerosch,

Johannes Flechtenmacher

Publication year - 2018

Publication title -

orthopedic reviews

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.412

H-Index - 13

eISSN - 2035-8237

pISSN - 2035-8164

DOI - 10.4081/or.2018.7782

Subject(s) - medicine , guideline , osteoarthritis , pharmacotherapy , intensive care medicine , german , scientific evidence , physical therapy , alternative medicine , pathology , psychiatry , philosophy , archaeology , epistemology , history

The pharmacological treatment of knee osteoarthritis (OA) is a purely symptomatic therapy, which often ensures that the mobility of the patient is successfully retained. This article refers to the recommendations and opinions regarding the pharmacotherapy of knee OA contained in the new guideline of the Association of the Scientific Medical Societies in Germany (AWMF), highlighting several important aspects and describing the considerations underlying the decision-making process. With this article it is hoped that therapeutic effectiveness can be realistically estimated, that any risks of medication errors and avoidable side effects can be reduced, and that further helpful measures can be taken into consideration.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research